AQP4 and glioblastoma: This knowledge provides a vital clinical and translational foundation for the design of new strategies, as targeting fluid dynamics (for example, through the modulation of AQP4 or the use of the perivascular route for drug delivery) offers a novel target to potentially overcome GBM resistance [6].